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Understanding the Effects of Endocrine Disruptors on the Glucocorticoid Signaling Pathway
Dana N. Joseph
Abstract
Endocrine disruptors are exogenous chemicals that interfere with the functions of the
endocrine system and can cause adverse developmental, reproductive, and neurological
effects. Unlike toxic effects that may be evident immediately, disruption to the endocrine
system may impact complex signaling pathways that take years or generations to discover.
Current toxicology testing does not routinely incorporate endpoints that would identify
potential endocrine disruptors. The objective of this study was to evaluate the endocrine
disrupting potential of a broad range of industrial chemicals, specifically focusing on four
chemicals with predicted activity on the glucocorticoid receptor (GR): 4-nonylphenol, bisphenol
A (BPA), butylated hydroxytoluene (BHT), and phenolphthalein (PP). These chemicals are used
in detergents, paints, pesticides, personal care products, and plastics. We have focused on
glucocorticoids because these hormones play a critical role in reproduction, development,
metabolism, and overall physiological homeostasis. Their actions are mediated by GR, a
transcription factor that is necessary for life. Thus, endocrine disrupting chemicals that alter
glucocorticoid signaling have the potential to alter the physiology of several organs and tissues.
Human liver (HepG2) and Ishikawa (uterine) cell lines were used to study the effects of these
chemicals on metabolism and reproduction, respectively. In Ishikawa and HepG2 cells, the
industrial chemicals differentially regulated the transcript levels of both glucocorticoid
responsive genes studied (GILZ and PER1). Interestingly, the effects of industrial chemical on
gene expression varied by cell type. Additionally, the industrial chemicals altered the
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phosphorylation status of two phosphorylated GR proteins (pGR-211 and pGR-226). A
combination of chemicals causes unique effects compared to individual chemicals. Collectively,
this suggests that the evaluated chemicals demonstrate gene- and cell-type specific effects.
These findings demonstrate that the endocrine disrupting potential of commonly used
industrial chemicals is an underappreciated potential source of toxicity.
Keywords: endocrine disruptors, glucocorticoids, industrial chemicals, toxicity, bisphenol A,
butylated hydroxytoluene, phenolphthalein, 4-nonylphenol, chronic disease epidemiology
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1. Introduction
Endocrine disruptors are chemicals that disrupt the normal functioning of the endocrine
system which can result in changes to hormone signaling and bodily functions [1]. While
endocrine disruptors don’t necessarily cause cell necrosis or immediate toxicity, they have been
shown to have demonstrated effects on gene signaling and protein expression in low
concentrations in animal models [2]. Endocrine disruptors can exert effects on hormone
pathways in the body in various ways, including competing with endogenous hormones for
substrate active sites, changing the rate of production and metabolism of endogenous
hormones, altering the levels of co-activators, and changing the epigenetic makeup of cells [3].
Much of the research on endocrine disruptors has focused on industrial chemicals involved in
plastic production as well as petroleum manufacturing [4, 5]. The annual global production of
plastics and petroleum has increased from 50 million to 300 million since the 1970s, and the
chemicals involved in these processes have been found to be endocrine-disrupting chemicals
[6].
The potential effects of endocrine disruptors on the reproductive system are particularly
important as endocrine disruptors can interrupt the delicate hormone signaling that is crucial to
a variety of reproductive processes, including successfully reaching puberty in both males and
females, creating a uterine environment receptable to embryo implantation, and carrying a
pregnancy to term [7]. Reproductive homeostasis depends on tightly regulated interactions
between organs, timing, stage of development, and hormone concentrations, and aberrant
behavior due to exogenous chemicals can cause adverse downstream signaling and a variety of
homeostatic and reproductive consequences [8].
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Studies have documented that BPA and PBDEs, which are commonly used to increase
the flexibility of plastic and vinyl, exert adverse changes on the neuroendocrine pathways
fundamental to reproductive health [9, 10]. There is also evidence that endocrine disruptors
induce aberrant changes to germ cells [11]. A significant body of research has been devoted to
exploring the effects of BPA, a chemical found in plastics polycarbonate plastics and epoxy
resins and often used in containers that store food and beverages. BPA exposure during a
woman’s reproductive years has been shown to compromise embryo implantation [12]. In
Denmark, women under 40 working in the plastics industry were more likely to have sought
fertility assistance than unexposed women of the same age [13].
The role of industrial chemicals, which are found ubiquitously and are a source of both
environmental and occupational exposure, has been vastly understudied. Recent studies have
shown the effects of industrial chemicals on the estrogen receptor, showing that industrial
chemicals can act as endocrine disruptors and have the potential to alter reproductive signaling
in uterine tissue [14]. Glucocorticoids, which are steroid hormones present in nearly every cell
type and involved in many inflammatory processes, including several reproductive pathways,
play a critical role in reproduction, development, metabolism, and overall physiological
homeostasis [15]. Therefore, it is important to understand the potential effects that endocrine
disruptors can have on glucocorticoid signaling at both the gene and protein levels of
expression. This research will allow individuals to infer (from their level of exposure) the
potential effects of these industrial chemicals on their metabolism and may provide women of
reproductive age information related to the effects of exposure on their fertility. The specific
effects of industrial chemicals on reproductive health and metabolism is a topic that has been
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understudied in endocrine research. Thus, this project would lend invaluable information to the
field of endocrinology and to the healthcare of those exposed to these environmental agents.
This project studied chemicals with reported glucocorticoid receptor activity determined
by a variety of reporter assays (receptor binding, agonist/antagonist activity, response element
binding) as documented in the ToxCast dashboard. Studies were performed with the following
chemicals: 4-nonylphenol (4-NP), bisphenol A (BPA), butylated hydroxytoluene (BHT), and
phenolphthalein (PP). Ishikawa (uterine) cells were utilized to examine the effects of endocrine
disruptors on glucocorticoid signaling and reproductive. HepG2 (liver) cells were utilized to
examine the effects of endocrine disruptors on glucocorticoid and metabolism. Both Ishikawa
and HepG2 cells have demonstrated levels of glucocorticoid signaling that mediate
inflammatory processes including reproductive function and metabolism.
2. Materials and Methods
2.1 Literature Search
A list of 139 chemicals with reproductive health hazard properties used in the industrial
chemical industry was developed based on several regulatory and advisory lists, including the
ToxCast database, Malaysia's Department of Occupational Safety and Health's Industry Code of
Practice (ICOP), Germany's Substance Database (GESTIS), Japan's National Institute of
Technology and Evaluation (NITE), and the European Chemicals Agency (ECHA). The
reproductive classification was based on the Globally Harmonized System (GHS) for
classification and labeling. We conducted a literature review in PubMed using the web browser
Google Chrome and following query: “[chemical name] and ‘endocrine disruptor’” or “[CAS #]
and ‘endocrine disruptor’”, notating the total number of published studies. A relevant hit was
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defined as a published study that directly investigated the endocrine disrupting effects of the
given chemical rather than include the chemical as part of the experimental design. The ToxCast
dashboard, which covers 1000 high-throughput endpoints for over 9000 chemicals, was
searched for active nuclear receptor endpoints, focusing on nuclear receptors with known
functions in the reproductive system through the glucocorticoid receptor (GR). Chemicals with
reported glucocorticoid receptor activity determined by a variety of reporter assays (receptor
binding, agonist/antagonist activity, response element binding) as documented in the ToxCast
database and demonstrating limited data related to their EDC effects were prioritized for in
vitro experiments. Studies were performed with the following chemicals: 4-nonylphenol (4-NP),
bisphenol A (BPA), butylated hydroxytoluene (BHT), and phenolphthalein (PP).
2.2 Reagents
Dulbecco’s Modified Eagle’s Medium (DMEM) and RPMI 1640 Medium was purchased from Life
Technologies Inc. (Carlsbad, CA). Fetal bovine serum (FBS) was purchased from Sigma-Aldrich
(St. Louis, MO). Charcoal dextran-treated (stripped) FBS was purchased from Gemini BioProducts (Sacramento, CA). TaqMan qRT-PCR primer-probes were purchased from Applied
Biosystems (ThermoFisher Scientific, Waltham, MA). Dexamethasone (Dex; 1, 4-pregnadien-9αfluoro-16α-methyl-11β, 17, 21-triol-3, 20-dione; ≥98% TLC), cortisol (Cort;
4-pregnen-11β, 17, 21-triol-3, 20-dione), and mifepristone (RU-486; 11β-[4(dimethylamino)phenyl]-17β-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-1; 97% by TLC) were
purchased from Steraloids (Newport, RI). Betamethasone (Beta; 9α-Fluoro-11β,17α,21trihydroxy-16β-methylpregna-1,4-diene-3,20-dione; 98.6% by HPLC) was purchased from MP
Biomedical (Solon, OH). Butylated hydroxytoluence (2,6-di-tert-butyl-4-methylphenol) and
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bisphenol A was purchased from Sigma Aldrich (St Louis, MO). Phenolphthalein was purchased
from Fisher Scientific (Hampton, NH). 4-n-nonylphenol was purchased from Alfa Aesar
(Haverhill, MA).
2.3 Cell culture
HepG2 cells were obtained from the Yale School of Medicine Department of Obstetrics,
Gynecology, and Reproductive Sciences. Short tandem repeat analysis was conducted on
HepG2 cells at the DNA Analysis Facility at Yale University to authenticate the cell line.
Immortalized human uterine endometrial adenocarcinoma (Ishikawa) cells were obtained from
ATCC (Manassas, VA). Both Ishikawa and HepG2 cell lines were grown in standard conditions
with 5% carbon dioxide. Immortalized human uterine endometrial adenocarcinoma (Ishikawa)
cells were maintained in RPMI 1640 supplemented with 5% FBS. Twenty-four hours prior to
treatment, cell medium was changed to phenol red-free RPMI 1640 containing 5% stripped FBS.
HepG2 cells were grown in DMEM supplemented with 10% FBS, 1.0 mM sodium pyruvate, 1
mM glutamine, and 100 U/mL penicillin/streptomycin. Twenty-four hours prior to experiments,
cell medium was changed to phenol red-free DMEM containing 10% FBS, 1.0 mM sodium
pyruvate, 1mM glutamine, 100 U/mL penicillin/streptomycin. Cells were treated with chemicals
over a range of doses below the reported limit of toxicity.
2.4 RNA extraction
Total RNA was harvested from the Ishikawa and HepG2 cells using the Qiagen RNeasy Mini Kit
(Qiagen, Valencia, CA). Total RNA quantity and purity was assessed using the NanoDrop One
Spectrophotometer (Thermo Fisher Scientific) based on the absorbance ratios at 260 and
280 nmol/L and at 260 and 230 nmol/L.
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2.5 Quantitative real-time polymerase chain reaction (qRT-PCR)
mRNA abundance was determined using a TaqMan One-Step procedure on the CFX Connect
Real-Time System (Bio-Rad Laboratories, Herculues, CA) with predesigned TaqMan assays
(Thermo Fisher Scientific). Quantitative RT-PCR was performed in a 10 μL reaction volume with
the following thermocycling parameters: 48°C for 30 minutes, 95°C for 10 minutes, 40 cycles of
95°C for 15 seconds, and 60°C for 60 seconds. A standard curve was used to calculate
expression values for each gene. The signal from each probe was normalized to the reference
gene peptidylprolyl-isomerase B (PPIB). A total of 100 ng of total RNA was used as input. There
were at least four biological replicates per treatment group and each gene primer probe was
evaluated with a technical duplicate for each sample.
2.6 Protein Isolation and Western blotting
Tris-glycine SDS sample buffer supplemented with 2-mercaptoethanol was used to lyse cells.
Total protein was quantified using the Pierce 660 nm protein assay kit (Thermo Fisher
Scientific). 40 ng of protein from each sample was run on a stain-free, precast gel, separated by
SDS-PAGE, and transferred to a nitrocellulose membrane (Bio-Rad Laboratories). Membranes
were blocked with 7.5% skim milk in Tris-buffered saline and probed overnight with primary
antibodies against phosphorylated GR-211, phosphorylated GR-226, GR, and β-actin. The next
day, membranes were washed with 0.1% Tween-20 in TBS and incubated with secondary
antibody for 1 hour at room temperature. Immunoreactivity was visualized using the Odyssey
LI-COR imaging system (LI-COR Biosciences, Lincoln, NE). Protein levels were normalized to βactin expressed relative to control samples.
2.7 LDH Assay
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Cells were treated with 1 μM chemical for 6 hours. Then, cell media was collected, plated on a
96-well plate, and assayed using an absorbance of 490 nm. Lactate acid dehydrogenase (LDH)
release was measured using the Roche Cytotoxicity Detection Kit (Quebec, Canada) according
to the manufacturer's instructions.
2.8 Bioinformatic Analysis
QIAGEN Ingenuity Pathway Analysis (Build 463,341 M, Version 42,012,434, Qiagen) was used to
analyze datasets from NCBI GEO in order to extract overlapping genes and map them to
canonical functional pathways. The p-value of the overlap was calculated by the right-tail
Fisher's Exact Test. The relationship between chemical-associated genes and enriched diseases
and functions was visualized using Cytoscape, an open-source software platform for
integration, analysis, and visualization of networked data.
2.9 Statistical analysis
Data represent the average of at least three biological replicates and are presented as
means ± SEM. Statistical significance was determined by one-way ANOVA with Tukey's post-hoc
analysis using Graph Pad Prism software version 7.0. Significance was determined as *p < 0.05
or **p < 0.01.
3. Results
3.1 Chemical Classification and Literature Review
To evaluate the potential impact to human reproduction and development, 139
chemicals used in petroleum manufacturing were examined via the ToxCast database according
to their reproductive toxicity. The ToxCast database revealed that 40 of the 139 chemicals
altered the activity of the nuclear receptors in reporter assays. 9 of the 40 chemicals altered the
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activity of GR. We performed an additional literature search in PubMed for the 9 chemicals
identified to alter GR activity and the term “glucocorticoid receptor.” We identified 4 chemicals
that had limited published data related to their endocrine disrupting potential and
glucocorticoid receptor activity and selected these chemicals for in vitro experimentation. The
four chemicals chosen for experimentation were 4-nonylphenol (4-NP), bisphenol A (BPA),
butylated hydroxytoluene (BHT), and phenolphthalein (PP).
In addition to their use in petroleum manufacturing, these four chemicals are found in a
variety of products used across industries, including food additives, personal care products, oil
and gas production, plastic manufacturing, dry cleaning reagents, and other manufacturing
processes [14]. The chemical and CAS number, exposure source, exposure route, and exposure
limit, molecular weight, and molecular structure were determined for each chemical (Fig. 1).
The routes of exposure include inhalation, ingestion, and skin or eye contact. The 8-hour
permissible exposure limit with time-weighted average as determined by the National Institute
for Occupational Safety and Health (NIOSH) and the State of California's Occupational Safety
and Health Administration are listed. NIOSH exposure limits were converted to molarity and are
listed in Figure 1.
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Figure 1. Description of the selected chemicals: 2,6-di-tert-butyl-p-cresol (butylated
hydroxytoluene) (BHT), 4,4’-isopropylidenediphenol (bisphenol A) (BPA), 4-nonylphenol (4-NP),
and phenolphthalein (PP), including the CAS number, description of the sources, routes, and
limits of. Exposure limits are determined as the 8-hour permissible exposure limit with timeweighted average.
3.2 Baseline glucocorticoid activity in Ishikawa and HepG2 cells
Initial in vitro experimentation involved confirming glucocorticoid activity in both cell
lines used in this study. GILZ and PER1 are genes activated by the glucocorticoid receptor.
Demonstrated GILZ and PER1 activity confirms literature documentation of strong GR activity in
these cell lines (Figure 2) [16, 17].
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B

Figure 2. Demonstrated GR activity in HepG2 and Ishikawa cell lines treated with vehicle,
dexamethasone, or cortisol and the expression of GR-responsive genes GILZ and PER1. A)
HepG2 cell line GR activity. B) Ishikawa cell line GR activity.
3.3 LDH activity of selected chemicals
LDH assay was used to assess whether treatment of the chemicals induced cell
death/cytotoxicity as a function of plasma membrane damage. Cells were treated with
chemicals at 1 μM concentrations, and LDH activity after 6 hours was measured. None of the
chemicals demonstrated cytotoxic effects in either HepG2 or Ishikawa cell lines.

Figure 3. LDH activity from
HepG2 and Ishikawa cell lines
after being treated with 1 μM
chemical for 6 hours.
3.4 In vitro exposure of
selected chemicals in
isolation and expression of endogenous
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glucocorticoid-responsive genes
Each cell line was treated with 10, 100, or 1000 nM of each of the four selected
chemicals for 6 hours (Figure 4). Gene expression of GR-responsive genes GILZ and PER1 were
measured. Treatments of 1000 nM BHT, 1000 nM 4-NP, 100 nM BPA, and 1000 nM BPA
induced statistically significant upregulation of both GILZ and PER1 in HepG2 cells. Treatment of
1000 nM PP induced statistically significant downregulation of both genes in HepG2 cells. The
results differ by cell type. No significant change in gene expression was observed from BHT
treatments in Ishikawa cells. Treatments of 1000 nM BPA, all concentrations of 4-NP, 100 nM
PP, and 1000 nM PP were found to significantly upregulate GILZ and PER1 expression in
Ishikawa cells (Figure 4).
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Figure 4. Gene expression data of GILZ and PER1 genes from dose-response treatments of 101000 nM. A) HepG2 cells. B) Ishikawa cells.
3.5 In vitro exposure of select chemicals in combination and expression of endogenous
glucocorticoid-responsive genes in HepG2 cells
Based on the results from the treatments with chemicals in isolation, the effects of
chemicals in combination were examined through various dose response treatments. Chemical
combinations were made based on results from Figure 4 to produce effects that would
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theoretically supersede the effects of the chemical in isolation. In Figure 4A, we demonstrate
that 10 nM of BPA or 4-NP alone doesn’t significantly upregulate GILZ expression, but together
they do. For the same treatment, there is no significant upregulation of PER1. Co-treatment of
4-NP and BHT also produces significant upregulation of GILZ expression that does not occur
when the chemicals are treated in isolation. (Figure 5B). This combination does not produce
significant upregulation of PER1. Treatment with 100 nM BPA alone induces significant
upregulation of both GILZ and PER1, and co-treatment of BPA and BHT produces significant
upregulation of both GILZ and PER1 (Figure 5C). The results of the co-treatment of chemicals in
HepG2 cells demonstrates that the effects of the chemicals differ by gene.

Figure 5. Gene expression data of GILZ and
PER1 genes from 10 nM chemical combination
treatments in HepG2 cells. A) Gene expression
from treatments of 10 nM BPA and 4-NP in
isolation and combined for 6 hours. B) Gene
expression from treatments of 100 nM 4-NP
and BHT in isolation and combined for 6
hours. C) Gene expression from treatments of
100 nM BHT and BPA in isolation and
combined for 6 hours.
3.6 In vitro exposure of select chemicals in combination and expression of endogenous
glucocorticoid-responsive genes in Ishikawa cells
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Based on the results from the treatments with chemicals in isolation (Figure 4), the
effects of chemicals in combination were examined through various dose response treatments.
Chemical combinations were made based on results from Figure 4 to produce effects that
would supersede the effects of the chemical in isolation. In Figure 6A, co-treatment of 10 nM
BPA and 10 nM 4-NP leads to downregulation of GILZ expression compared to the upregulation
observed during treatment of 10 nM 4-NP alone. This co-treatment leads to significant
upregulation of PER1 expression. Co-treatment of 10 nM BPA and 10 nM PP leads to significant
upregulation of both GILZ and PER1 expression (Figure 6B). In Figure 6C, co-treatment of 10 nM
BHT and 10 nM PP leads to downregulation of GILZ expression compared to the upregulation
observed during treatment of 10 nM PP alone. This co-treatment leads to significant
upregulation of PER1 expression. Co-treatment of 10 nM 4-NP and 10 nM PP leads to significant
upregulation of both GILZ and PER1 expression (Figure 6D).
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Figure 6. Gene expression data of GILZ
and PER1 genes from dose-response
treatments of 10 nM chemical
combinations in Ishikawa cells. A) Gene
expression from treatments of 10 nM
BPA and 4-NP in isolation and combined
for 6 hours. B) Gene expression from
treatments of 10 nM BPA and PP in
isolation and combined for 6 hours. C)
Gene expression from treatments of 10
nM BHT and PP in isolation and combined
for 6 hours. D) Gene expression from
treatments of 4-NP nM BHT and PP in
isolation and combined for 6 hours.

3.7 In vitro exposure of artificial corticosteroid dexamethasone in combination with selected
chemicals and expression of endogenous glucocorticoid-responsive genes in HepG2 and
Ishikawa cells
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BHT did not attenuate the upregulatory effects of dexamethasone on GILZ and PER1
expression in both HepG2 and Ishikawa cells (Figure 7A). BPA significantly downregulated the
effects of dexamethasone on both GILZ and PER1 expression in both HepG2 and Ishikawa cells
(Figure 7B). 4-NP significantly downregulated the effects of dexamethasone on both GILZ and
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PER1 expression in both HepG2 and Ishikawa cells (Figure 7C). PP did not attenuate the
upregulatory effects of dexamethasone on GILZ and PER1 expression in both HepG2 and
Ishikawa cells (Figure 7D).
3.8 Protein expression from cells treated with selected chemicals and dexamethasone
Cells treated with 100 nM of chemical were probed for pGR-226 through Western blot.
Dex, BHT, PP, and 4-NP significantly upregulated pGR-226 expression in both HepG2 and
Ishikawa cells.

Figure 8. HepG2 cells treated with
100 nM of dexamethasone, BHT, BPA,
PP, and 4-NP and probed for pGR-226
through Western blot.

Figure 9. Ishikawa cells treated with
100 nM of dexamethasone, BHT, BPA,
PP, and 4-NP and probed for pGR-226
through Western blot.

3.9 Bioinformatic gene networks regulated by selected chemicals in animal models
Ingenuity Pathway Analysis (IPA) was used to analyze data from rat liver cells treated
with dexamethasone, BPA, 4-NP, and PP. IPA highlighted genes that were significantly
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upregulated (green) or downregulated (red) according to treatments with the chemical (Figure
8).

Figure 10. Genes regulated by chemical in rat liver cells. Genes regulated by dexamethasone,
BPA, 4-NP, and PP were identified through the NCBI GEO database and analyzed through the
Ingenuity Pathway Analysis (IPA) software. Genes upregulated are marked in green and genes
downregulated are marked in red.
IPA was also used to generate heat maps linking the four chemical treatments to
canonical pathways and molecular and cellular functions associated with the glucocorticoid
receptor and related pathways (Figure 9). The chemicals have differential regulation on the
pathways and molecular and cellular functions as seen by the range of activation z-scores. PP
strongly downregulates calcium signaling while 4-NP has a higher activation score.
Dexamethasone has a weak downregulatory activity effect while BPA has a weak upregulatory
activity effect. Dexamethasone and BPA do not cause activity changes for Huntington’s disease
signaling while both dexamethasone and PP have high activity z-scores for that same pathway.
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Figure 11. Rat liver gene expression data. Darker blue indicates downregulatory activity
(inhibition) while darker orange indicates upregulatory activity (activation).
Discussion
Glucocorticoid activity was demonstrated in both Ishikawa and HepG2 cells in Figure 1,
allowing our candidate genes of GILZ and PER1 to be appropriate choices for measuring GR
activity (Figure 2). LDH assays showed no cytotoxic effects of the selected chemicals on either
HepG2 or Ishikawa cell lines, indicating that the endocrine disrupting effect is not immediately
toxic (Figure 3).
While the selected chemicals don’t display toxic effects, they do play a role in regulating
GR-mediated gene expression levels in both cell lines (Figures 1-7). In HepG2 cells, BPA and BHT
upregulate expression of both GILZ and PER1 while PP downregulates expression of both genes
(Figure 4). In HepG2 cells, 4-NP upregulates GILZ expression while not influencing PER1 gene
levels (Figure 4). Additionally, treatment of cells with multiple chemicals allows for upregulation
of gene expression that cannot be achieved with treatment of one chemical alone. Cotreatment of 4-NP and BHT in HepG2 cells produces significant upregulation of GILZ expression
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that does not occur when the chemicals are treated in isolation. (Figure 5B). Co-treatment of
BPA and PP in Ishikawa cells produces significant upregulation of GILZ expression that only
occurs when BPA is treated in isolation but not when PP is treated in isolation (Figure 6B). This
demonstrates the ability for chemicals in combination to have greater effects than chemicals
alone. In petroleum manufacturing and products that contain these endocrine disruptors, it is
very common for multiple chemicals to be present.
Not only do the gene expression effects differ by chemical, but these results were also
found to differ by cell type. BHT treatments in HepG2 cells upregulate GILZ and PER1 expression
while not having an effect in Ishikawa cells (Figure 4). We see similar patterns for other
treatment types in which gene regulation in one cell type is either not present or attenuated in
the other cell type (Figures 5, 6). This suggests differences in the GR binding complexes
between liver and uterine cells which causes the chemicals to interact with GR differently.
It has been well documented that gene expression is fine-tuned to meet the needs of a
cell [18]. The glucocorticoid receptor regulates target genes by associating with specific DNA
binding sites, the sequences of which differ between genes [19]. These binding sites have been
conventionally viewed only as docking sites, but recent work using structural, biochemical, and
cell-based assays has shown that GR binding sequences, differing by as little as a single base
pair, differentially affect GR conformation and regulatory activity [20].
Perhaps the treatment of the industrial chemicals alters the binding properties of GR
which leads to functional differences in gene expression. GR utilizes hormones as allosteric
effectors of their transcriptional regulatory activity, and additional inputs, such as
phosphorylation, also affect GR function [20, 21]. Thus, the binding of selected chemicals from
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competitive, uncompetitive, or noncompetitive binding to GR could alter the allosteric effects
of GR and its ability to translocate to the nucleus [22]. Upon translocation, the chemically
modified GR could differentially bind to DNA sequences in the nucleus which would cause
differential activation of transcription factors which would ultimately lead to changes in gene
expression between cell types.
Differences in the phosphorylation of the GR binding complexes between the Ishikawa
(uterine) and HepG2 (liver) cells can also account for the difference in gene expression between
the two cell lines. GR can be phosphorylated to different levels in each cell type. The pGR-226
protein levels were upregulated through treatment with 100 nM of dexamethasone, BHT, BPA,
PP, and 4-NP in both HepG2 and Ishikawa cells (Figures 8, 9). [23]. The phosphorylation levels of
pGR-211 have yet to be quantified and may be different from the levels of pGR-226 measured.
Thus, GR may be more susceptible to conformational changes and phosphorylation from
allosteric binding from chemicals in one cell type over another. Chemicals can thus act as partial
agonists or antagonists and either interfere or upregulate naturally occurring GR signaling.
The chemicals could also be altering the epigenetic landscape of GR through
conformational changes of the receptor. We have shown that treatment of cells with artificial
corticosteroid dexamethasone as well as the selected chemicals can either interrupt, enhance,
or antagonize the normal effects of dexamethasone (Figure 7). This suggests that not only can
the chemicals bind to GR, but they can also compete with other hormones in various ways to
cause downstream gene effects. This demonstrates the allosteric nature of GR in which multiple
ligands can bind before the receptor translocates to the nucleus and binds to transcription
factors [24].
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Conclusion
Pending experiments in this project include synthesizing western blot data from to
quantify fold changes in protein expression of phosphorylated GR-211 and evaluating the
effects of co-treatment of the selected chemicals with RU486 (mifepristone). The antibodies
targeted for the Western blot are two phosphorylated forms of GR, pGR-211 and pGR-226,
which are two serine residues that are commonly phosphorylated before translocation of the
receptor complex to the nucleus. Understanding changes in protein expression after treatment
with the selected chemicals will allow us to see whether gene expression changes translate to
changes at the protein level. The Western blots have been completed; quantification of pGR211 remains.
Co-treatment of cells with the selected chemicals and RU486 is another pending
experiment which will be critical to examining whether the treatments interfere or aid with the
natural inhibition caused by mifepristone. RU486 is a known glucocorticoid receptor antagonist
that interferes with steroid-mediated inflammatory activity [25]. The interaction of the selected
chemicals with RU486 could either attenuate its inhibitory properties, increase the antagonist
behavior, or have some other behavior. This experiment will further elucidate the interactions
of the selected chemicals with other hormones in the body.
In summary, the four industrial chemicals selected altered the gene expression of GRmediated elements in human uterine and liver cells. We have demonstrated that these
chemicals exert gene-level changes that differ depending on cell type. Additionally, we have
shown that chemicals in combination can exert greater gene effects than chemicals in isolation.
Finally, our bioinformatics work has allowed for an expanded view of the various pathways and
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molecular/cellular functions involved in these cell lines and the proteins involved in the shifted
signaling because of the selected chemicals. As these chemicals are present in a variety of
products used daily, this work has wide applications and can inform individuals on their level of
endocrine disrupting chemical exposure and the risks associated with those exposures. This
study focused on two GR-responsive genes, but we look forward to expanding to genome-wide
studies so that a larger scope of canonical pathways connected to molecular and cellular
functions can be derived. Our pending experiments on protein expression and treatment with a
GR antagonist (RU486) will further elucidate the endocrine disrupting potential of industrial
chemicals.

27

References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.

Latini, G., et al., Endocrine disruptors and human health. Mini Rev Med Chem, 2010.
10(9): p. 846-55.
Julien, B., et al., Evidence for estrogeno-mimetic effects of a mixture of low-dose
pollutants in a model of ovariectomized mice. Environ Toxicol Pharmacol, 2018. 57: p.
34-40.
Yilmaz, B., et al., Endocrine disrupting chemicals: exposure, effects on human health,
mechanism of action, models for testing and strategies for prevention. Rev Endocr
Metab Disord, 2020. 21(1): p. 127-147.
Wagner, M. and J. Oehlmann, Endocrine disruptors in bottled mineral water: total
estrogenic burden and migration from plastic bottles. Environ Sci Pollut Res Int, 2009.
16(3): p. 278-86.
Kassotis, C.D., et al., Endocrine-Disrupting Chemicals and Oil and Natural Gas
Operations: Potential Environmental Contamination and Recommendations to Assess
Complex Environmental Mixtures. Environ Health Perspect, 2016. 124(3): p. 256-64.
Takahashi, K., T. Hanaoka, and G. Pan, Male reproductive health in relation to
occupational exposure to endocrine disrupting and other potent chemicals, a review of
the epidemiologic literature. J UOEH, 2004. 26(1): p. 23-40.
Costa, E.M., et al., Effects of endocrine disruptors in the development of the female
reproductive tract. Arq Bras Endocrinol Metabol, 2014. 58(2): p. 153-61.
Brieno-Enriquez, M.A., E. Larriba, and J. Del Mazo, Endocrine disrupters, microRNAs, and
primordial germ cells: a dangerous cocktail. Fertil Steril, 2016. 106(4): p. 871-9.
Harley, K.G., et al., PBDE concentrations in women's serum and fecundability. Environ
Health Perspect, 2010. 118(5): p. 699-704.
Matuszczak, E., et al., The Impact of Bisphenol A on Fertility, Reproductive System, and
Development: A Review of the Literature. Int J Endocrinol, 2019. 2019: p. 4068717.
Brieno-Enriquez, M.A., et al., Exposure to endocrine disruptor induces transgenerational
epigenetic deregulation of microRNAs in primordial germ cells. PLoS One, 2015. 10(4): p.
e0124296.
Pivonello, C., et al., Bisphenol A: an emerging threat to female fertility. Reprod Biol
Endocrinol, 2020. 18(1): p. 22.
Kloukos, D., N. Pandis, and T. Eliades, Bisphenol-A and residual monomer leaching from
orthodontic adhesive resins and polycarbonate brackets: a systematic review. Am J
Orthod Dentofacial Orthop, 2013. 143(4 Suppl): p. S104-12 e1-2.
Alofe, O., et al., Determining the endocrine disruption potential of industrial chemicals
using an integrative approach: Public databases, in vitro exposure, and modeling
receptor interactions. Environ Int, 2019. 131: p. 104969.
Schug, T.T., et al., Endocrine disrupting chemicals and disease susceptibility. J Steroid
Biochem Mol Biol, 2011. 127(3-5): p. 204-15.
Whirledge, S., L.T. Senbanjo, and J.A. Cidlowski, Genistein disrupts glucocorticoid
receptor signaling in human uterine endometrial Ishikawa cells. Environ Health Perspect,
2015. 123(1): p. 80-7.

28

17.
18.
19.
20.
21.
22.
23.
24.
25.

Psarra, A.M. and C.E. Sekeris, Glucocorticoids induce mitochondrial gene transcription in
HepG2 cells: role of the mitochondrial glucocorticoid receptor. Biochim Biophys Acta,
2011. 1813(10): p. 1814-21.
Mohtat, D. and K. Susztak, Fine tuning gene expression: the epigenome. Semin Nephrol,
2010. 30(5): p. 468-76.
Roux, S., et al., Conformational change in the human glucocorticoid receptor induced by
ligand binding is altered by mutation of isoleucine 747 by a threonine. J Biol Chem, 1999.
274(15): p. 10059-65.
Meijsing, S.H., et al., DNA binding site sequence directs glucocorticoid receptor structure
and activity. Science, 2009. 324(5925): p. 407-10.
Parsonnet, N.V., et al., The glucocorticoid receptor DNA-binding domain recognizes RNA
hairpin structures with high affinity. Nucleic Acids Res, 2019. 47(15): p. 8180-8192.
Chow, C.C. and S.S. Simons, Jr., An Approach to Greater Specificity for Glucocorticoids.
Front Endocrinol (Lausanne), 2018. 9: p. 76.
Chen, W., et al., Glucocorticoid receptor phosphorylation differentially affects target
gene expression. Mol Endocrinol, 2008. 22(8): p. 1754-66.
Weikum, E.R., et al., Glucocorticoid receptor control of transcription: precision and
plasticity via allostery. Nat Rev Mol Cell Biol, 2017. 18(3): p. 159-174.
Takeshita, Y., et al., Blockade of glucocorticoid receptors with RU486 attenuates cardiac
damage and adipose tissue inflammation in a rat model of metabolic syndrome.
Hypertens Res, 2015. 38(11): p. 741-50.

29

